These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 17918768)

  • 1. Design, synthesis and evaluation of peptide inhibitors of Mycobacterium tuberculosis ribonucleotide reductase.
    Nurbo J; Roos AK; Muthas D; Wahlström E; Ericsson DJ; Lundstedt T; Unge T; Karlén A
    J Pept Sci; 2007 Dec; 13(12):822-32. PubMed ID: 17918768
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of small peptides mimicking the R2 C-terminus of Mycobacterium tuberculosis ribonucleotide reductase.
    Ericsson DJ; Nurbo J; Muthas D; Hertzberg K; Lindeberg G; Karlén A; Unge T
    J Pept Sci; 2010 Mar; 16(3):159-64. PubMed ID: 20127854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Design, synthesis, and evaluation of octahydropyranopyrrole-based inhibitors of mammalian ribonucleotide reductase.
    Fuertes MJ; Kaur J; Deb P; Cooperman BS; Smith AB
    Bioorg Med Chem Lett; 2005 Dec; 15(23):5146-9. PubMed ID: 16176875
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rational design and 3D-pharmacophore mapping of 5'-thiourea-substituted alpha-thymidine analogues as mycobacterial TMPK inhibitors.
    Andrade CH; Pasqualoto KF; Ferreira EI; Hopfinger AJ
    J Chem Inf Model; 2009 Apr; 49(4):1070-8. PubMed ID: 19296716
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new family of inhibitors of Mycobacterium tuberculosis thymidine monophosphate kinase.
    Gasse C; Huteau V; Douguet D; Munier-Lehmann H; Pochet S
    Nucleosides Nucleotides Nucleic Acids; 2007; 26(8-9):1057-61. PubMed ID: 18058536
    [No Abstract]   [Full Text] [Related]  

  • 6. Structure-based design of a potent and selective small peptide inhibitor of Mycobacterium tuberculosis 6-hydroxymethyl-7, 8-dihydropteroate synthase: a computer modelling approach.
    Rao GS; Kumar M
    Chem Biol Drug Des; 2008 Jun; 71(6):540-5. PubMed ID: 18482337
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of a novel class of potent inhibitors of InhA, the enoyl acyl carrier protein reductase from Mycobacterium tuberculosis: a computer modelling approach.
    Subba Rao G; Vijayakrishnan R; Kumar M
    Chem Biol Drug Des; 2008 Nov; 72(5):444-9. PubMed ID: 19012578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A discovery of novel Mycobacterium tuberculosis pantothenate synthetase inhibitors based on the molecular mechanism of actinomycin D inhibition.
    Yang Y; Gao P; Liu Y; Ji X; Gan M; Guan Y; Hao X; Li Z; Xiao C
    Bioorg Med Chem Lett; 2011 Jul; 21(13):3943-6. PubMed ID: 21641210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design, synthesis and biological evaluation of sugar-derived esters, alpha-ketoesters and alpha-ketoamides as inhibitors for Mycobacterium tuberculosis antigen 85C.
    Sanki AK; Boucau J; Umesiri FE; Ronning DR; Sucheck SJ
    Mol Biosyst; 2009 Sep; 5(9):945-56. PubMed ID: 19668859
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis and biological evaluation of new inhibitors of UDP-Galf transferase--a key enzyme in M. tuberculosis cell wall biosynthesis.
    Cren S; Gurcha SS; Blake AJ; Besra GS; Thomas NR
    Org Biomol Chem; 2004 Sep; 2(17):2418-20. PubMed ID: 15326520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformationally restricted hydantoin-based peptidomimetics as inhibitors of caspase-3 with basic groups allowed at the S3 enzyme subsite.
    Vázquez J; García-Jareño A; Mondragón L; Rubio-Martinez J; Pérez-Payá E; Albericio F
    ChemMedChem; 2008 Jun; 3(6):979-85. PubMed ID: 18393268
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis and biological activities of triazole derivatives as inhibitors of InhA and antituberculosis agents.
    Menendez C; Gau S; Lherbet C; Rodriguez F; Inard C; Pasca MR; Baltas M
    Eur J Med Chem; 2011 Nov; 46(11):5524-31. PubMed ID: 21944473
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 3D-QSAR studies on antitubercular thymidine monophosphate kinase inhibitors based on different alignment methods.
    Aparna V; Jeevan J; Ravi M; Desiraju GR; Gopalakrishnan B
    Bioorg Med Chem Lett; 2006 Feb; 16(4):1014-20. PubMed ID: 16290929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Peptide conjugates of therapeutically used antitubercular isoniazid-design, synthesis and antimycobacterial effect.
    Horváti K; Mezo G; Szabó N; Hudecz F; Bosze S
    J Pept Sci; 2009 May; 15(5):385-91. PubMed ID: 19319854
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition studies of Mycobacterium tuberculosis salicylate synthase (MbtI).
    Manos-Turvey A; Bulloch EM; Rutledge PJ; Baker EN; Lott JS; Payne RJ
    ChemMedChem; 2010 Jul; 5(7):1067-79. PubMed ID: 20512795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Novel pseudopeptides incorporating a benzodiazepine-based turn mimetic--targeting Mycobacterium tuberculosis ribonucleotide reductase.
    Nurbo J; Ericsson DJ; Rosenström U; Muthas D; Jansson AM; Lindeberg G; Unge T; Karlén A
    Bioorg Med Chem; 2013 Apr; 21(7):1992-2000. PubMed ID: 23395111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functionalized 3-amino-imidazo[1,2-a]pyridines: a novel class of drug-like Mycobacterium tuberculosis glutamine synthetase inhibitors.
    Odell LR; Nilsson MT; Gising J; Lagerlund O; Muthas D; Nordqvist A; Karlén A; Larhed M
    Bioorg Med Chem Lett; 2009 Aug; 19(16):4790-3. PubMed ID: 19560924
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure-based prediction of Mycobacterium tuberculosis shikimate kinase inhibitors by high-throughput virtual screening.
    Segura-Cabrera A; Rodríguez-Pérez MA
    Bioorg Med Chem Lett; 2008 Jun; 18(11):3152-7. PubMed ID: 18486472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure-based design, synthesis and preliminary evaluation of selective inhibitors of dihydrofolate reductase from Mycobacterium tuberculosis.
    El-Hamamsy MH; Smith AW; Thompson AS; Threadgill MD
    Bioorg Med Chem; 2007 Jul; 15(13):4552-76. PubMed ID: 17451962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel 4-(morpholin-4-yl)-N'-(arylidene)benzohydrazides: synthesis, antimycobacterial activity and QSAR investigations.
    Raparti V; Chitre T; Bothara K; Kumar V; Dangre S; Khachane C; Gore S; Deshmane B
    Eur J Med Chem; 2009 Oct; 44(10):3954-60. PubMed ID: 19464085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.